UPL Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call analysis: revenue, margin, capex, fundraise and order book outlook from management commentary.

Published 25 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹48.0K Cr

UPL expects full-year revenue growth of 7% to 11% for FY27. UPL expects full-year revenue growth of 7% to 11% and EBITDA growth of 10% to 14% for FY27.

From UPL Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Price

₹583

Market Cap

₹48.0K Cr

P/E Ratio

24.3

How does UPL Ltd rank in Fertilizers & Agrochemicals?

Compare UPL Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 4Margin: Rank 3

View Fertilizers & Agrochemicals leaderboard →

UPL Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹18.3K Cr, net profit ₹1.3K Cr.

Full financials →

📊 Revenue & Sales Performance

Rank 4

→UPL expects full-year revenue growth of 7% to 11% for FY27.
→Volume growth is anticipated especially in the seeds and super specialty businesses, with super specialty showing sustained multi-year growth.
→Global Crop Protection (CP) volume growth is expected to improve during the year, supported by market share gains and cautious channel inventory management.
→India CP business expects strong performance due to hyperscale brands, innovation, and improved product mix.
→Latam volumes are expected to be strong from Q2 onwards, particularly in Brazil with the upcoming planting season.
→Pricing is proactive with increases incorporated to offset cost inflation, with no expected price decline.
→New product launches are expected to generate $115 million in revenue during the year, contributing to growth.
→Overall, volume growth combined with pricing actions underpin confident revenue and EBITDA guidance.

📈 Profitability & Margins

Rank 3

→UPL expects full-year revenue growth of 7% to 11% and EBITDA growth of 10% to 14% for FY27.
→EBITDA margins are anticipated to improve, not decline, continuing a 7-quarter trend of margin expansion.
→Margin improvement driven by pricing discipline, better mix, lower input costs, and operational excellence.
→India business margins expected to be materially higher than last year, though some seasonality is factored.
→Volume growth expected in seeds and super specialty businesses; cautious inventory management in crop protection to avoid oversupply.
→Earnings improvements seen as structural, with PAT turning positive after 3 years.
→Continued focus on profitable growth, margin expansion, and deleveraging supports confident outlook.
→No expected significant forex gains beyond Q1, guidance based on constant currency.
→Investments in innovation and new product launches to contribute $115 million revenue this year.

See what UPL Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

Yes

→In Q1 FY27, UPL made capital investments amounting to ₹669 crores, primarily related to their associate Sinova in Brazil (Page 15).
→The company has planned additional capex and strategic investments, which contributed to net debt being flat year-on-year in U.S. dollar terms despite debt reduction (Page 5).
→There is no explicit mention of future capex commitments or amounts, but UPL continues investing to drive growth and innovation, indicated by advances in their "Advanced Planning System" and commercialization of new products (Page 8).
→UPL also mentioned investment in specialty platforms that support growth in super specialty and ag segments (Page 14).
→Overall, UPL emphasizes disciplined capital management and sustaining investments aligned with long-term value creation (Pages 5 & 8).

💰 Fundraising & Capital Structure

→UPL has no immediate fundraising plans through debt or equity announced in Q1 FY27.
→The company mentioned existing debt obligations: $500 million due in December 2026 and another $500 million in FY28.
→The $400 million debt due in September was refinanced and extended by 3 years.
→UPL has $300 million committed revolving credit facility (RCF) and $2 billion of uncommitted working capital lines.
→Management stated they will assess refinancing needs in the coming months based on market conditions.
→No new equity fundraising was mentioned; however, the Advanta IPO process is ongoing but subject to regulatory timelines.
→Overall, UPL is confident about meeting debt obligations comfortably with internal cash flows and existing liquidity.

See what UPL Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

Yes

→For the upcoming planting season in Brazil, the channel is starting to load, finalizing harvest of the second corn season, with planting beginning in September-October for the new soybean crop.
→The company is well-positioned with a strong order book.
→Customers have been cautious in loading inventory, buying just in time due to geopolitical conflicts and pricing uncertainties.
→The order book and channel positioning give UPL confidence for strong volume growth in Q2, Q3, and Q4.
→The company is taking orders with the channel and expects growth driven by in-season demand.
→Overall, there is a cautious but confident outlook for volume recovery and order fulfillment across key markets.

Key Metrics

2 of 5 growth signals positive in the Q1 FY27 call.

Revenue

Rank 4

Margin

Rank 3

Capex

Yes

Fundraise

Order Book

Yes

How does UPL Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1UPL Ltd

Rev 4Mar 3

See full Fertilizers & Agrochemicals sector rankings

What UPL's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

GSP Crop Science Ltd (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
RALLIS (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.
Coromandel International Ltd (Q1 FY27)
Specialty Nutrient business growing consistently at 25%-30% with high EBITDA margins (~20%). Key concall takeaways from Coromandel Inter's Q1 FY27 earnings…
MOL (Q1 FY27)
Capacity utilization likely to stay around 40-50%. Key concall takeaways from Meghmani Organics Ltd's Q1 FY27 earnings call — and how it ranks against sector…

Compare:vs Coromandel International Ltd vs FACT vs PIIND

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were UPL Ltd Q1 FY27 results?

UPL expects full-year revenue growth of 7% to 11% for FY27. UPL expects full-year revenue growth of 7% to 11% and EBITDA growth of 10% to 14% for FY27.

What is UPL Ltd share price analysis?

UPL Ltd currently shows a neutral. The stock trades at a P/E of 24.3 with a market cap of ₹48,018 Cr. Investors should review the full earnings analysis for detailed insights.

Is UPL Ltd planning capital expenditure?

In Q1 FY27, UPL made capital investments amounting to ₹669 crores, primarily related to their associate Sinova in Brazil (Page 15). - The company has planned additional capex and strategic investments, which contributed to net debt being flat year-on-year in U.S.

Keep UPL Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.